Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
 | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
November 8, 2024
[edit]Renamed
[edit]- 3-Methylbutanoic acid renamed to Isovaleric acid.
Reassessed
[edit]- Bavdegalutamide (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- Fazamorexant (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- The Shulgin Index (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- Vafidemstat (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
- XW10508 (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Assessed
[edit]- Amphetamine type stimulant (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Isovaleric acid (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Pharmacology of ethanol (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- UH15-38 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
November 7, 2024
[edit]Reassessed
[edit]- Category:Amphetamines (talk) reassessed. Quality rating changed from Category-Class to Redirect-Class. (rev · t)
- Anthraquinone (talk) reassessed. Quality rating changed from Stub-Class to B-Class. (rev · t)
- Crisnatol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Assessed
[edit]- Vafidemstat (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
November 6, 2024
[edit]Reassessed
[edit]- 5-MBPB (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- AAZ-A-154 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Alpertine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Ariadne (drug) (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
- Ciclindole (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Drug discrimination (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- LSM-775 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- MYCO-005 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Metitepine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Oxypertine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Assessed
[edit]- Bexirestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Category:Drug manufacturing (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
November 5, 2024
[edit]Assessed
[edit]- 3-Methoxymethcathinone (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Amcenestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Drug discrimination (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Giredestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Palazestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
November 4, 2024
[edit]Renamed
[edit]- Draft:The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds renamed to The Shulgin Index.
- Draft:XW10508 renamed to XW10508.
Assessed
[edit]- Rintodestrant (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Taragarestrant (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- The Shulgin Index (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
November 3, 2024
[edit]Renamed
[edit]- Labcorp Drug Development renamed to Fortrea.
Assessed
[edit]- Fortrea (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
- List of Kappa Epsilon chapters (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Draft:The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Draft:XW10508 (talk) assessed. Importance assessed as NA-Class. (rev · t)
November 2, 2024
[edit]Assessed
[edit]- Category:Australian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Austrian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Bangladeshi pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Belgian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:British pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Canadian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Chinese pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Croatian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Czech pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Danish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Drugs developed by Takeda Pharmaceutical Company (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Dutch pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:English pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:French pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:German pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Ghanaian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Hungarian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Irish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Italian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- MYCO-005 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Category:Norwegian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Otsuka Pharmaceutical (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pakistani pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Palestinian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Template:Pharmaceutical Affordability and Access (talk) assessed. Quality assessed as Template-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pharmaceutical industry in China (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pharmaceutical industry in Germany (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pharmaceutical industry in Pakistan (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pharmaceutical industry in the United Kingdom (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pharmacologists by nationality (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Pharmacology journals (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Polish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Portuguese pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Russian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Rwandan pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Saudi Arabian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Scottish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Shenyang Pharmaceutical University (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Shenyang Pharmaceutical University alumni (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Spanish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Sri Lankan pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Streptothricin (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Category:Swedish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Syrian pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Taiho Pharmaceutical (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Turkish pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Category:Ugandan pharmacologists (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)